Budesonide and Poractant Alfa prevent bronchopulmonary dysplasia via triggering SIRT1 signaling pathway.
Sign Up to like & getrecommendations! Published in 2019 at "European review for medical and pharmacological sciences"
DOI: 10.26355/eurrev_201912_19811
Abstract: OBJECTIVE This study aimed to evaluate effect of budesonide combining Poractant Alfa on preventing bronchopulmonary dysplasia (BPD). PATIENTS AND METHODS A total of 120 preterm infants were involved. pH value, partial pressure of oxygen (PO2),… read more here.
Keywords: sirt1; bronchopulmonary dysplasia; poractant alfa; group ... See more keywords